checkAd

     572  0 Kommentare NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine - Seite 3

    Investor Contact:
    Gordon Link
    Chief Financial Officer
    515-598-2925
    glink@linkp.com

    Lesen Sie auch


    Seite 3 von 3

    Verfasst von Marketwired
    3 im Artikel enthaltene WerteIm Artikel enthaltene Werte
    NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine - Seite 3 AMES, IA--(Marketwired - Aug 5, 2014) - NewLink Genetics Corporation (NASDAQ: NLNK), through its wholly owned subsidiary, BioProtection Systems Corporation (BPS), today announced a letter contract with the United States Defense Threat Reduction …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer